Susquehanna International Group, LLP Paratek Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $133,672 - $199,826	68,200 Added 568.33%	80,200 $206,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $73,352 - $131,016	-42,400 Reduced 77.94%	12,000 $23,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $87,912 - $114,480	-21,600 Reduced 28.42%	54,400 $244,000
Q3 2021 Nov 15, 2021	BUY	$4.7 - $7.24 $305,030 - $469,876	64,900 Added 584.68%	76,000 $369,000
Q1 2021 May 17, 2021	SELL	$6.14 - $8.31 $960,296 - $1.3 Million	-156,400 Reduced 93.37%	11,100 $78,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $9,618 - $14,994	-2,100 Reduced 1.24%	167,500 $1.05 Million
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $170,114 - $271,614	40,600 Added 31.47%	169,600 $918,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $265,518 - $466,668	89,400 Added 225.76%	129,000 $673,000
Q1 2020 May 15, 2020	SELL	$2.67 - $4.97 $85,173 - $158,543	-31,900 Reduced 44.62%	39,600 $125,000
Q3 2019 Nov 14, 2019	BUY	$3.08 - $5.76 $102,256 - $191,232	33,200 Added 86.68%	71,500 $309,000
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $117,920 - $159,280	-22,000 Reduced 36.48%	38,300 $205,000
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $199,680 - $482,560	-41,600 Reduced 40.82%	60,300 $309,000
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $717,060 - $977,170	70,300 Added 222.47%	101,900 $1.04 Million
Q1 2018 May 15, 2018	SELL	$12.65 - $18.85 $82,225 - $122,525	-6,500 Reduced 17.06%	31,600 $411,000
Q4 2017 Feb 14, 2018	SELL	$17.45 - $25.6 $2.67 Million - $3.91 Million	-152,800 Reduced 80.04%	38,100 $682,000
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $3.61 Million - $5.38 Million	190,900	190,900 $4.79 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account